← Back to Search

Brain Stimulation

Active tDCS for Age-Related Macular Degeneration

N/A
Recruiting
Led By Ben Thompson, PhD
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the tests will take roughly 5 minutes to complete, and they will be roughly 7-10 weeks apart.

Summary

This trial is testing whether a-tDCS, a kind of brain stimulation, can be combined with perceptual learning to improve the ability of people with age-related or juvenile macular degeneration to read words on a computer screen.

Who is the study for?
This trial is for adults with stable vision and diagnosed age-related macular degeneration (AMD) or juvenile macular degeneration (JMD), who have a visual acuity between 6/9-6/96 in the better eye. Participants must be fluent in English or Chinese characters, depending on location, and not have had recent ocular surgery except under specific conditions.
What is being tested?
The study tests if brain stimulation called anodal transcranial direct current stimulation (a-tDCS), combined with perceptual learning, can improve reading ability on a computer screen for those with AMD or JMD. Half of the participants will receive real stimulation while the other half get sham treatment to compare effectiveness.
What are the potential side effects?
While not explicitly listed, side effects may include discomfort at the electrode site from tDCS, potential headaches, tingling sensations during application, fatigue after sessions, and possibly transient mood changes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the tests will take roughly 5 minutes to complete, and they will be roughly 7-10 weeks apart.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the tests will take roughly 5 minutes to complete, and they will be roughly 7-10 weeks apart. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Rapid Serial Visual Presentation (RSVP) Reading performance 30 days after training
Change in Rapid Serial Visual Presentation (RSVP) Reading performance before and right after training.
Secondary study objectives
Change in Contrast Sensitivity before and 30 days after training
Change in Contrast Sensitivity before and just after training
Change in Crowded Visual Acuity before and 30 days after training
+5 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active + TrainingActive Control1 Intervention
Participants in this arm will be exposed to active stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
Group II: Sham + TrainingPlacebo Group1 Intervention
Participants in this arm will be exposed to sham stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.

Find a Location

Who is running the clinical trial?

University of WaterlooLead Sponsor
127 Previous Clinical Trials
214,802 Total Patients Enrolled
The Hong Kong Polytechnic UniversityOTHER
534 Previous Clinical Trials
73,915 Total Patients Enrolled
Ben Thompson, PhDPrincipal InvestigatorUniversity of Waterloo
2 Previous Clinical Trials
55 Total Patients Enrolled

Media Library

Active anodal tDCS (Brain Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT04762368 — N/A
Age-Related Macular Degeneration Research Study Groups: Sham + Training, Active + Training
Age-Related Macular Degeneration Clinical Trial 2023: Active anodal tDCS Highlights & Side Effects. Trial Name: NCT04762368 — N/A
Active anodal tDCS (Brain Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04762368 — N/A
~6 spots leftby Dec 2025